Key information made simple
This summary needs review. Please check the official study record and contact the research team for details.
CompletedNCT01072630
Armodafinil Treatment (150 and 200 mg/Day) for depression
This study is completed in the United States, in Australia, in France, .... It is testing Armodafinil Treatment (150 and 200 mg/Day) for depression.
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
Check the study details
Check the official source, then confirm these points with the research team.
View official study record (opens in a new tab)
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
Study start dateMarch 2010
- Recruitment status
- Completed
- Enrollment listed in the registry
- 492
- Sponsor
- Cephalon
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, Australia, France, ...
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01072630
- Official title
- A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT01072630. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
View official study record (opens in a new tab)The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
Argentina · 6 sites
- Dr. Gregorio Hugo SorinBuenos Aires, Buenos AiresSite status: Not listed — confirm with the team
- INECOBuenos Aires, Buenos AiresSite status: Not listed — confirm with the team
- Instituto FLENIBuenos Aires, Buenos AiresSite status: Not listed — confirm with the team
- Sanatorio Prof. León S. Morra SACórdoba, Córdoba ProvinceSite status: Not listed — confirm with the team
- Centro de Investigación y asistencia en Psiquiatria (CIAP)Rosario, RosarioSite status: Not listed — confirm with the team
- B.A. Psychiatric Research CentBuenos AiresSite status: Not listed — confirm with the team
Australia · 2 sites
- Neurotherapy Victoria Clinical TrialsMalvern, VictoriaSite status: Not listed — confirm with the team
- Northern Area Mental Health Services Northern Psychiatric RMelbourne, VictoriaSite status: Not listed — confirm with the team
Bulgaria · 8 sites
- MHAT DoverieSofia, SofiaSite status: Not listed — confirm with the team
- Psychiatric clinic, University Hospital "Alexandrovska"Sofia, SofiaSite status: Not listed — confirm with the team
- MHAT - Sveta MarinaVarna, VarnaSite status: Not listed — confirm with the team
- District Department of Psychiatric Disorders With StationaryBurgasSite status: Not listed — confirm with the team
- State Psychiatric Hospital - PazardjikPazardzhikSite status: Not listed — confirm with the team
- Psychiatric clinic for women UMHAT "Dr. Georgi Stranski"PlevenSite status: Not listed — confirm with the team
- ODPZS- EOOD, Plovdiv, BulgariaPlovdivSite status: Not listed — confirm with the team
- Diagnostic Consultative Center "Tchaika"VarnaSite status: Not listed — confirm with the team
Canada · 5 sites
- Grey Nuns HospitalEdmonton, AlbertaSite status: Not listed — confirm with the team
- Dr. Alexander McIntyre, Inc.Penticton, British ColumbiaSite status: Not listed — confirm with the team
- Providence Care Mental Health ServicesKingston, OntarioSite status: Not listed — confirm with the team
- Medical Research AssociatesMississauga, OntarioSite status: Not listed — confirm with the team
- Hôpital Louis HlafontaineMontreal, QuebecSite status: Not listed — confirm with the team
France · 3 sites
- CMP/CHS du JuraDoleSite status: Not listed — confirm with the team
- Centre Hospitalier de JonzacJonzacSite status: Not listed — confirm with the team
- Hopital Universitaire Caremeau-Batiment Polyvalent, ServiceNîmesSite status: Not listed — confirm with the team
Poland · 4 sites
- Szpital Uniwersytecki im.dr.A.Jurasza w BydgoszczyBydgoszcz, BydgoszczSite status: Not listed — confirm with the team
- Klinika Chorob Psychicznych i Zaburzen Nerwicowych GUMGdanskSite status: Not listed — confirm with the team
- Wojewodzki Szpital Psychiatryczny im. prof. Tadeusza BilikieGdanskSite status: Not listed — confirm with the team
- Malopolskie Centrum MedyczneKrakowSite status: Not listed — confirm with the team
South Africa · 7 sites
- Cape Trial CentreCape TownSite status: Not listed — confirm with the team
- Flexivest Fourteen Research CentreCape TownSite status: Not listed — confirm with the team
- Knighton SurgeryCape TownSite status: Not listed — confirm with the team
- Vista ClinicCenturionSite status: Not listed — confirm with the team
- Dr Magnus & Dr BrinkJohannesburgSite status: Not listed — confirm with the team
- Paarl Medical CentrePaarlSite status: Not listed — confirm with the team
- Dey ClinicPretoriaSite status: Not listed — confirm with the team
Spain · 4 sites
- Hospital del HenaresCoslada (Madrid)Site status: Not listed — confirm with the team
- Clínica Universitaria de NavarraPamplonaSite status: Not listed — confirm with the team
- Hospital Psiquiátrico de ÁlavaVitoria-GasteizSite status: Not listed — confirm with the team
- Hospital Santiago ApostolVitoria-GasteizSite status: Not listed — confirm with the team
Ukraine · 7 sites
- Danylo Galitsky Lviv State Medical UniversityLviv, Lviv OblastSite status: Not listed — confirm with the team
- Odessa Regional Mental Hospital #2S. Oleksandrivka, Odesa OblastSite status: Not listed — confirm with the team
- Vinnytsa National Medical University named by M.I. PirogovVinnitsa, VinnitsaSite status: Not listed — confirm with the team
- Donetsk National Medical University n.a. M. HorkyyDonetskSite status: Not listed — confirm with the team
- Public Institution "Institute of Neurology, Psychiatry and NKharkivSite status: Not listed — confirm with the team
- Kiev City Psychoneurological Hospital N 1, CNTRPKievSite status: Not listed — confirm with the team
- Odessa Regional Psychoneurology DispensaryOdesaSite status: Not listed — confirm with the team
United States · 46 sites
- Birmingham Psychiatry Pharmaceutical Studies, IncBirmingham, AlabamaSite status: Not listed — confirm with the team
- South Coast Medical Associates/SC Clinical Trials, Inc.Anaheim, CaliforniaSite status: Not listed — confirm with the team
- Comprehensive NeuroScienceCerritos, CaliforniaSite status: Not listed — confirm with the team
- Sun Valley Behavioral MedicalImperial, CaliforniaSite status: Not listed — confirm with the team
- North County Clinical ResearchOceanside, CaliforniaSite status: Not listed — confirm with the team
- CNRI Los Angeles LLCPico Rivera, CaliforniaSite status: Not listed — confirm with the team
- CNRI-San Diego LLCSan Diego, CaliforniaSite status: Not listed — confirm with the team
- Clinical Innovations Inc.Santa Ana, CaliforniaSite status: Not listed — confirm with the team
- Schuster Medical Research InstituteSherman Oaks, CaliforniaSite status: Not listed — confirm with the team
- Stanford University Medical CenterStanford, CaliforniaSite status: Not listed — confirm with the team
- Viking Clinical Research CenterTemecula, CaliforniaSite status: Not listed — confirm with the team
- Comprehensive NeuroScienceWashington D.C., District of ColumbiaSite status: Not listed — confirm with the team
- Scientific Clinical Research, Inc.Aventura, FloridaSite status: Not listed — confirm with the team
- Florida Clinical Research CenterBradenton, FloridaSite status: Not listed — confirm with the team
- Clinical Neuroscience Solutions IncJacksonville, FloridaSite status: Not listed — confirm with the team
- Fidelity Clinical ResearchLauderhill, FloridaSite status: Not listed — confirm with the team
- Compass Research, LLCOrlando, FloridaSite status: Not listed — confirm with the team
- Stedman Clinical Trials, LLCTampa, FloridaSite status: Not listed — confirm with the team
- Atlanta Center for Medical ResearchAtlanta, GeorgiaSite status: Not listed — confirm with the team
- Carman ResearchSmyrna, GeorgiaSite status: Not listed — confirm with the team
- Hawaii Clinical Research CenterHonolulu, HawaiiSite status: Not listed — confirm with the team
- Midwest Center for Neurobehavioral MedicineOakbrook Terrace, IllinoisSite status: Not listed — confirm with the team
- CNS - Comprehensive Neuro SciencePark Ridge, IllinoisSite status: Not listed — confirm with the team
- Community ResearchCrestview Hills, KentuckySite status: Not listed — confirm with the team
- AccelRx ResearchFall River, MassachusettsSite status: Not listed — confirm with the team
- Mayo College of MedicineRochester, MinnesotaSite status: Not listed — confirm with the team
- Precise Research CentersFlowood, MississippiSite status: Not listed — confirm with the team
- CRI Worldwide, LLCMount Laurel, New JerseySite status: Not listed — confirm with the team
- Behavioral Medical Research of BrooklynBrooklyn, New YorkSite status: Not listed — confirm with the team
- Fieve Clinical Services, Inc.New York, New YorkSite status: Not listed — confirm with the team
- Medical and Behavioral Health ResearchNew York, New YorkSite status: Not listed — confirm with the team
- Behavioral Medical Research of Staten IslandStaten Island, New YorkSite status: Not listed — confirm with the team
- Richmond Behavioral AssociatesStaten Island, New YorkSite status: Not listed — confirm with the team
- North Coast Clinical Trials, Inc.Beachwood, OhioSite status: Not listed — confirm with the team
- Neuro-Behavioral Clinical Research, IncCanton, OhioSite status: Not listed — confirm with the team
- IPS Research CompanyOklahoma City, OklahomaSite status: Not listed — confirm with the team
- Oregon Center for Clinical Investigators, Inc. (OCCI, Inc.)Portland, OregonSite status: Not listed — confirm with the team
- Lehigh Center for Clinical ResearchAllentown, PennsylvaniaSite status: Not listed — confirm with the team
- Belmont Center for Comprehensive TreatmentPhiladelphia, PennsylvaniaSite status: Not listed — confirm with the team
- FutureSearch Trials of NeurologyAustin, TexasSite status: Not listed — confirm with the team
- Insite Clinical ResearchDeSoto, TexasSite status: Not listed — confirm with the team
- Red Oak Psychiatry Associates, P.A.Houston, TexasSite status: Not listed — confirm with the team
- University Hills Clinical ResearchIrving, TexasSite status: Not listed — confirm with the team
- Aspen Clinical Research, LLCOrem, UtahSite status: Not listed — confirm with the team
- Clinical MethodsSalt Lake City, UtahSite status: Not listed — confirm with the team
- Alliance Research GroupRichmond, VirginiaSite status: Not listed — confirm with the team
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Armodafinil, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with bipolarity; age range: From 18 Years to 65 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Cephalon, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedEUCTR 2004-003826-92
"A Randomized, Parallel Group, Open Trial Examining the Safety, Efficacy and Tolerability of Fast Titration, 800mg/day by day 4, of Quetiapine Fumarate Compared to Standard Titration, 400mg/day by ...
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
CompletedNCT00223496
12- Week Open Label Treatment of Refractory Depression in bipolarity
This study is completed. It focuses on bipolarity and currently lists study information in the United States.
CompletedNCT02363738
12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression
This study is completed. It focuses on bipolarity and currently lists study information in Canada and the United States.